Discovery of RNA-targeted small molecules through the merging of experimental and computational technologies
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 9, 2022 Category: Drugs & Pharmacology Authors: Ella Czarina Morishita Source Type: research

The state of the art of fetal hemoglobin-inducing agents
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 7, 2022 Category: Drugs & Pharmacology Authors: Aline Renata Pavan Juliana Romano Lopes Jean Leandro Dos Santos Source Type: research

Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 18, 2022 Category: Drugs & Pharmacology Authors: Sofia D ’Souza Prema Kv Seetharaman Balaji Source Type: research

Strategies for the drug discovery and development of taxane anticancer therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 15, 2022 Category: Drugs & Pharmacology Authors: Changwei Wang Angelo Aguilar Iwao Ojima Source Type: research

Latest models for the discovery and development of rheumatoid arthritis drugs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 13, 2022 Category: Drugs & Pharmacology Authors: Bartosz Szostak Anna Gor ący Bart łomiej Pala Jakub Rosik Łukasz Ustianowski Andrzej Pawlik Source Type: research

Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway
Volume 17, Issue 9, September 2022, Page 1029-1045 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 8, 2022 Category: Drugs & Pharmacology Authors: Joanna Panecka-Hofman Ina Poehner Rebecca C. Wade Source Type: research

Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 8, 2022 Category: Drugs & Pharmacology Authors: Joanna Panecka-Hofman Ina Poehner Rebecca C. Wade Source Type: research

The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 6, 2022 Category: Drugs & Pharmacology Authors: Deniz Lengerli K übra Ibis Yahya Nural Erden Banoglu Source Type: research

Library size in virtual screening: is it truly a number ’s game?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 5, 2022 Category: Drugs & Pharmacology Authors: Maria Kontoyianni Source Type: research

The latest guidance on the simultaneous design of virtually active and non-hemolytic peptides
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 28, 2022 Category: Drugs & Pharmacology Authors: Alejandro Speck-Planche Valeria V. Kleandrova Source Type: research